Accelerant ARX
- Market cap
- $4.3B
- PE
- n/m
- a loss over the last year
- Forward PE
- n/m
- not a meaningful number
- Price to sales
- 3.7×
- EV/EBIT
- n/m
- a loss over the last year
- Revenue, 12 months
- $1.1B
- +55% on a year ago
- Net margin
- n/m
- outside −100% to 100%
- Free cash flow yield
- n/m
- not a meaningful number
Accelerant trades at 3.7× sales. Its trailing earnings are negative, so it has no PE. Revenue was $1.1B over the last twelve months, up 55% on a year earlier.
Charts
Financials
| Income statement | Q1 FY24 | Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 |
|---|---|---|---|---|---|---|---|---|---|---|
| $128.1M | $130.1M | $153.7M | $190.7M | $178M+39% | $219.1M+68% | $267.4M+74% | $248.4M+30% | $273.3M+54% | $356.9M+63% | |
| SG&A | $49.1M | $57.8M | $67.3M | $71.3M | $75.3M+53% | $89.1M+54% | $115.8M+72% | $120.2M+69% | $123.8M+64% | $129.5M+45% |
| Interest expense | $3M | $3M | $3.1M | $3M | $2.6M−13% | $2.5M−17% | $2.6M−16% | $3.2M+7% | $2.5M−4% | $2.4M−4% |
| Pre-tax income | $12M | −$4.3M | $1.3M | $23M | $15.5M+29% | $22.3M | −$1.4B | −$2.2M | $2M−87% | $87.4M+292% |
| $9.9M | $4.9M | −$8.1M | $2.4M | $7.7M−22% | $9.2M+88% | $9.5M | −$3.1M | $6.1M−21% | $7.4M−20% | |
| Net income | $7.1M | −$9M | $8.1M | $21M | $6.5M−9% | $8.8M | −$1.4B | −$600K | −$5.2M | $78.7M+794% |
| $0.04 | −$0.05 | $0.04 | $0.10 | $0.03−25% | $0.04 | −$6.99 | $0.00 | −$0.02 | $0.36+800% | |
| 165.6M | 165.9M | 199.7M | 200.5M | 205.3M+24% | 205.9M+24% | 206.1M+3% | 221.8M+11% | 222M+8% | 219.7M+7% |
Revenue: Q1 FY24 and Q1 FY25: 6 months less the 3 months printed beside them.
SG&A: Q1 FY24: 6 months less the 3 months printed beside them.
Interest expense: Q1 FY24 and Q1 FY25: 6 months less the 3 months printed beside them.
Pre-tax income: Q1 FY24 and Q1 FY25: 6 months less the 3 months printed beside them.
Income tax: Q1 FY24 and Q1 FY25: 6 months less the 3 months printed beside them.
Net income: Q1 FY24 and Q1 FY25: 6 months less the 3 months printed beside them.
EPS, diluted: 4 periods, Q1 FY24 to Q4 FY25: quarter's net income to common over its shares, to the cent.
Diluted shares: Q1 FY24: share-days: the 6-month average less the second quarter's. Q4 FY24: share-days: the 12-month average less the 9-month, weighted by days. Q4 FY25: a loss quarter: its basic count, share-days: the 12-month average less the 9-month, weighted by days.
From each company's 10-Q and 10-K filings, the newest version of each figure. Quarters are as filed (a fourth quarter is the year less its first nine months), fiscal years as the 10-K prints them, restated where a later 10-K restated them, and balance sheet lines as of the period's end. A quarter whose 10-Q isn't filed yet is from the company's results release. Growth is on the same period a year earlier. A dash is a period with no figure for the line: the filing doesn't print it, or it hasn't been read yet.
Peers
Companies in Insurance - Brokers nearest Accelerant's size, closest first.
| Company | Market cap | PE | Its 10y median PE | Fwd PE | P/S | Revenue growth | Net margin |
|---|---|---|---|---|---|---|---|
| ARXAccelerant | $4.3B | n/m | n/a | n/m | 3.7× | +55% | n/m |
| CRVLCorvel | $4.2B | 37.3× | 38.1× | n/m | 4.3× | +7% | 11.7% |
| NPNeptune Insurance | $3.9B | 91.7× | 126× | n/m | 19.9× | +34% | 22.7% |
| HGTYHagerty | $5.4B | 260× | 50.9× | n/m | 3.7× | +8% | 1.8% |
| ACTEnact | $6.6B | 10.1× | 7.8× | n/m | 5.3× | +2% | 54.5% |
| GSHDGoosehead Insurance | $1.7B | 39.8× | 175× | n/m | 4.3× | +18% | 8.8% |
| RYANRyan Specialty | $11.2B | 60.7× | 92.3× | n/m | 3.5× | +14% | 3.1% |
| TWFGTWFG | $1.5B | 47.1× | 45.8× | n/m | 5.2× | +35% | n/m |
| ERIEErie Indemnity | $13.3B | 23.0× | 31.6× | n/m | 3.2× | +4% | 14.0% |
| BROBrown & Brown | $24.4B | 21.8× | 29.1× | 15.7× | 3.6× | +34% | 17.7% |
| WTWWillis Towers Watson Public | $30.2B | 19.9× | 26.0× | 15.5× | 3.0× | +3% | 15.5% |
| Peer median | $6B | 38.5× | 41.9× | 15.6× | 4.0× | +11% | 14.0% |
Investors who own it
Investors we follow who held Accelerant at the end of Jun 30, 2026, from their 13F filings.
- Chase ColemanTiger Global Management0.0% of portfolio
More on Accelerant
Each number over time
Where it ranks
Its groups
About
- Industry
- Insurance - Brokers
- Sector
- Financial Services
Valuation data, not investment advice. Prices as of .